Maurice Y Mommaerts1, Paul R Depauw2, Erik Nout3. 1. European Face Centre, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium. 2. Department of Neurosurgery, GH Elisabeth-Tweesteden, Tilburg, The Netherlands. 3. Division of Oro-Maxillo-Facial Surgery, GH Elisabeth-Tweesteden, Tilburg, The Netherlands.
Abstract
STUDY DESIGN: Inlay cranioplasties following partial craniectomy in tumor or trauma cases and onlay cranioplasties for reconstructions of residual developmental skull anomalies are frequently performed using CAD-CAM techniques. OBJECTIVE: In this case series, we present a novel cranial implant design, being a combination of 3D-printed titanium grade 23 and calcium phosphate paste (CeTi). METHODS: The titanium patient-specific implant, manufactured using selective laser melting, has a latticed border with interconnected micropores. The cranioplasty is miniscrew fixed and its border zone subsequently partially filled with calcium phosphate paste to promote osteoinduction and osteoconduction. From April 2017 to April 2019, 8 patients have been treated with such a CeTi implant. The inlay cranioplasties were each time revision surgeries of complicated cases. RESULTS: All implants were successful after a limited follow-up time (range 18-42 months). There were no dehiscences and no infections, and no complaints of thermal conduction. CONCLUSIONS: The proposed CeTi cranial implant combines the strength of titanium implants with the biological integration potential of ceramic implants and seems particularly resistant to infection, probably due to the biofunctionalized titanium surface and the antimicrobial activity of elevated intracellular free calcium levels.
STUDY DESIGN: Inlay cranioplasties following partial craniectomy in tumor or trauma cases and onlay cranioplasties for reconstructions of residual developmental skull anomalies are frequently performed using CAD-CAM techniques. OBJECTIVE: In this case series, we present a novel cranial implant design, being a combination of 3D-printed titanium grade 23 and calcium phosphate paste (CeTi). METHODS: The titanium patient-specific implant, manufactured using selective laser melting, has a latticed border with interconnected micropores. The cranioplasty is miniscrew fixed and its border zone subsequently partially filled with calcium phosphate paste to promote osteoinduction and osteoconduction. From April 2017 to April 2019, 8 patients have been treated with such a CeTi implant. The inlay cranioplasties were each time revision surgeries of complicated cases. RESULTS: All implants were successful after a limited follow-up time (range 18-42 months). There were no dehiscences and no infections, and no complaints of thermal conduction. CONCLUSIONS: The proposed CeTi cranial implant combines the strength of titanium implants with the biological integration potential of ceramic implants and seems particularly resistant to infection, probably due to the biofunctionalized titanium surface and the antimicrobial activity of elevated intracellular free calcium levels.
Authors: A Fukuda; M Takemoto; T Saito; S Fujibayashi; M Neo; Deepak K Pattanayak; T Matsushita; K Sasaki; N Nishida; T Kokubo; T Nakamura Journal: Acta Biomater Date: 2011-02-02 Impact factor: 8.947
Authors: G Zhao; Z Schwartz; M Wieland; F Rupp; J Geis-Gerstorfer; D L Cochran; B D Boyan Journal: J Biomed Mater Res A Date: 2005-07-01 Impact factor: 4.396
Authors: Michael de Wild; Ralf Schumacher; Kyrill Mayer; Erik Schkommodau; Daniel Thoma; Marius Bredell; Astrid Kruse Gujer; Klaus W Grätz; Franz E Weber Journal: Tissue Eng Part A Date: 2013-09-19 Impact factor: 3.845
Authors: Roberto Stefini; Giacomo Esposito; Bruno Zanotti; Corrado Iaccarino; Marco Maria Fontanella; Franco Servadei Journal: Surg Neurol Int Date: 2013-01-28